Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-κB Non-Canonical Pathway and Mitochondrial Remodeling.
Autorzy:
Motta CS; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil. Torices S; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA. da Rosa BG; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil. Marcos AC; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Alvarez-Rosa L; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.; Laboratório Compartilhado, Instituto de Ciências Biomédicas, UFRJ, Rio de Janeiro 05508-000, Brazil. Siqueira M; Laboratório Compartilhado, Instituto de Ciências Biomédicas, UFRJ, Rio de Janeiro 05508-000, Brazil. Moreno-Rodriguez T; Urology Department, University of California San Francisco, San Francisco, CA 94143, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143, USA. Matos ADR; Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil. CaetanoBC; Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil. Martins JSCC; Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil. Gladulich L; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil. Loiola E; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil. Bagshaw ORM; Faculty of Mathematics & Science, Brock University, St. Catharines, ON L2S 3A1, Canada. Stuart JA; Faculty of Mathematics & Science, Brock University, St. Catharines, ON L2S 3A1, Canada. Siqueira MM; Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil. Stipursky J; Laboratório Compartilhado, Instituto de Ciências Biomédicas, UFRJ, Rio de Janeiro 05508-000, Brazil. Toborek M; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Adesse D; Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-360, Brazil.; Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Mar 14; Vol. 15 (3). Date of Electronic Publication: 2023 Mar 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020.
Autorzy:
Williams T; University of Edinburgh Edinburgh UK. Jackson S; World Health Organization Geneva Switzerland. Barr I; Peter Doherty Institute for Infection and Immunity WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Disease Reference Laboratory (VIDRL) Melbourne Victoria Australia.; Department of Microbiology and Immunology University of Melbourne Melbourne Victoria Australia. Bi S; United Kingdom Health Security Agency (UKHSA) London UK.; United Kingdom National External Quality Assessment Service (UK NEQAS) for Microbiology London UK. Bhiman J; Centre for Respiratory Diseases and Meningitis National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service Johannesburg South Africa.; School of Pathology, Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa. Ellis J; United Kingdom Health Security Agency (UKHSA) London UK. von Gottberg A; Centre for Respiratory Diseases and Meningitis National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service Johannesburg South Africa.; School of Pathology, Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa. Lindstrom S; Respiratory Virus Branch, Division of Viral Diseases Centers for Disease Control and Prevention Atlanta Georgia USA. Peret T; Division of Infectious Diseases, Department of Internal Medicine University of Texas Medical Branch Galveston Texas USA.; Institute for Human Infections and Immunity University of Texas Medical Branch Galveston Texas USA. Rughooputh S; United Kingdom Health Security Agency (UKHSA) London UK.; United Kingdom National External Quality Assessment Service (UK NEQAS) for Microbiology London UK. Viegas M; Virology Laboratory Ricardo Gutiérrez Children's Hospital Buenos Aires Argentina.; National Council for Scientific and Technological Research (CONICET) Buenos Aires Argentina. Hirve S; World Health Organization Geneva Switzerland. Zambon M; United Kingdom Health Security Agency (UKHSA) London UK. Zhang W; World Health Organization Geneva Switzerland. Dia N; Virology Department National Influenza Centre, Pasteur Institute of Dakar Dakar Senegal. Razanazatovo N; National Influenza Laboratory Institut Pasteur de Madagascar Antananarivo Madagascar. Al-Nabet ADMH; Qatar-HAMAD-NIC, Department of Laboratory Medicine and Pathology Hamad Medical Corporation Doha Qatar. Abubakar A; Central Public Health Laboratory Ministry of Health Cairo Egypt. Tivane A; Viral Isolation Laboratory, Department of Technological Platforms National Institute of Health/MISAU Marracuene Mozambique. Barakat A; Eastern Mediterranean Regional Office World Health Organization Cairo Egypt. Naguib A; Central Public Health Laboratory Ministry of Health Cairo Egypt. Aziz A; Peter Doherty Institute for Infection and Immunity WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Disease Reference Laboratory (VIDRL) Melbourne Victoria Australia. Vicari A; Pan American Health Organization Washington District of Columbia USA. Moen A; World Health Organization Geneva Switzerland. Govindakarnavar A; WHO Country Office Kathmandu Nepal. Hall A; Division of Viral Diseases, Respiratory Viruses Branch Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA. Darmaa B; Virology Laboratory National Center for Communicable Diseases Ulaanbaatar Mongolia. Nathalie B; Influenza and Respiratory Viruses Section, National Microbiology Laboratory Public Health Agency of Canada Winnipeg Manitoba Canada. Herring B; African Region Office World Health Organization Brazzaville Congo. CaetanoBC; Oswaldo Cruz Foundation Respiratory Virus Laboratory FIOCRUZ Rio de Janeiro Brazil. Whittaker B; Respiratory Diseases Branch (RDB), Division of Bacterial Diseases (DBD) Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA. Baumeister E; Respiratory Virosis Service, Virology Department INEI-ANLIS Dr. Carlos G Malbrán Buenos Aires Argentina. Nakouné E; Epidemiological Surveillance Pasteur Institute of Bangui Bangui Central African Republic. Guthrie E; International Reagent Resources (IRR), Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA. Inbanathan F; South-East Asia Region Office World Health Organization New Delhi India. Nair H; Medical School The University of Edinburgh Edinburgh UK. Campbell H; Usher Institute of Population Health Research and Informatics University of Edinburgh Edinburgh UK. Kadjo HA; Department of Epidemic Viruses Pasteur Institute of Ivory Coast Abidjan Côte d'Ivoire. Oumzil H; Virology Department, Manager of National Influenza Center National Institute of Hygiene, Ministry of Health Rabat Morocco. Heraud JM; National Influenza Laboratory Institut Pasteur de Madagascar Antananarivo Madagascar. Mott JA; US CDC Thailand sub-regional office Nonthaburi Thailand. Namulondo J; Uganda Virus Research Institute Entebbe Uganda. Leite J; Division of Viral Diseases, Respiratory Viruses Branch Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA. Nahapetyan K; Western Pacific Region Office World Health Organization Manila Philippines. Al Ariqi L; Eastern Mediterranean Region Office World Health Organization Cairo Egypt. Gazo MHI; Central Public Health Laboratory Ministry of Health Cairo Egypt. Chadha M; National Institute of Virology Indian Council of Medical Research Pune India. Pisareva M; Laboratory of Molecular Virology Smorodintsev Research Institute of Influenza St. Petersburg Russian Federation. Venter M; Center for Viral Zoonosis, Department of Medical Virology University of Pretoria Pretoria South Africa. Siqueira MM; Laboratorio de Virus Respiratorios, IOC/FIOCRUZ Rio de Janeiro Brazil. Lumandas M; Department of Health Research Institute for Tropical Medicine Muntinlupa Philippines. Niang M; Virology Department National Influenza Centre, Pasteur Institute of Dakar Dakar Senegal. Albuaini M; National Influenza Centre, Research Laboratory Rafic Hariri University Hospital Beirut Lebanon. Salman M; Central of Public Health Laboratory National Institute of Health Islamabad Pakistan. Oberste S; Division of Viral Diseases, Respiratory Viruses Branch Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA. Srikantiah P; Bill and Melinda Gates Foundation Seattle Washington USA. Tang P; Sidra Medicine Doha Qatar. Couto P; Division of Viral Diseases, Respiratory Viruses Branch Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA. Smith P; MRC International Statistics and Epidemiology Group London School of Hygiene and Tropical Medicine London UK. Coyle PV; Qatar-HAMAD-NIC, Department of Laboratory Medicine and Pathology Hamad Medical Corporation Doha Qatar. Dussart P; National Influenza Laboratory Institut Pasteur de Madagascar Antananarivo Madagascar. Nguyen PN; Western Pacific Region Office World Health Organization Manila Philippines. Okada PA; Department of Medical Sciences Respiratory virus section, Thai NIC, National Institute of Health Nonthaburi Thailand. Wijesinghe PR; South-East Asia Region Office World Health Organization New Delhi India. Samuel R; South-East Asia Region Office World Health Organization New Delhi India. Brown R; South-East Asia Region Office World Health Organization New Delhi India. Pebody R; Regional Office for Europe World Health Organization Copenhagen Denmark. Fasce R; Sub-department of Viral Diseases Institute of Public Health of Chile Santiago Chile. Jha R; National Public Health Laboratory, Department of Health Services Ministry of Health and Population Kathmandu Nepal. Lindstrom S; Division of Viral Diseases, Respiratory Viruses Branch Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA. Gerber S; Division of Viral Diseases, Respiratory Viruses Branch Centers for Disease Control and Prevention (CDC) Atlanta Georgia USA. Potdar V; National Institute of Virology Indian Council of Medical Research Pune India. Dong X; Peter Doherty Institute for Infection and Immunity WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Disease Reference Laboratory (VIDRL) Melbourne Victoria Australia. Deng YM; Peter Doherty Institute for Infection and Immunity WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Disease Reference Laboratory (VIDRL) Melbourne Victoria Australia.
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Jan 18; Vol. 17 (1), pp. e13073. Date of Electronic Publication: 2023 Jan 18 (Print Publication: 2023).
Sera of patients infected by earlier lineages of SARS-CoV-2 are capable to neutralize later emerged variants of concern.
Autorzy:
Pauvolid-Corrêa A; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil.; Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX 77843, USA.; Departamento de Veterinária, Universidade Federal de Viçosa (UFV), Viçosa, MG 36570-900, Brazil. CaetanoBC; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil. Machado AB; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil. Ferreira MA; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil. Valente N; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil. Neves TK; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil. Geraldo K; Instituto Nacional de Infectologia Evandro Chagas (INI), Fiocruz, Rio de Janeiro, RJ 21040-900, Brazil. Motta F; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil. Dos Santos VGV; Instituto Nacional de Infectologia Evandro Chagas (INI), Fiocruz, Rio de Janeiro, RJ 21040-900, Brazil. Grinsztejn B; Instituto Nacional de Infectologia Evandro Chagas (INI), Fiocruz, Rio de Janeiro, RJ 21040-900, Brazil. Siqueira MM; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil. Resende PC; Laboratório de Vírus Respiratórios e Sarampo, COVID-19 National Reference Laboratory of Brazil and World Health Organization COVID-19 Reference Laboratory, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ 21040-900, Brazil.
Pokaż więcej
Źródło:
Biology methods & protocols [Biol Methods Protoc] 2022 Aug 22; Vol. 7 (1), pp. bpac021. Date of Electronic Publication: 2022 Aug 22 (Print Publication: 2022).
Analysis of Viral and Host Factors on Immunogenicity of 2018, 2019, and 2020 Southern Hemisphere Seasonal Trivalent Inactivated Influenza Vaccine in Adults in Brazil.
Autorzy:
Capão A; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Aguiar-Oliveira ML; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. CaetanoBC; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Neves TK; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Resende PC; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Almeida WAF; Secretariat of Surveillance in Health (SVS), Ministry of Health (MoH), Brasília-Federal District, Rio de Janeiro 70723-040, Brazil. Miranda MD; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Martins-Filho OAS; Grupo Integrado de Pesquisas em Biomarcadores, René Rachou Institute, FIOCRUZ, Belo Horizonte 30190-002, Brazil. Brown D; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK. Siqueira MM; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Garcia CC; Laboratory of Respiratory Viruses and Measles, National Influenza Center (NIC)/World Health Organization (WHO), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Jul 30; Vol. 14 (8). Date of Electronic Publication: 2022 Jul 30.
Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2.
Autorzy:
Melgaço JG; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Azamor T; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Silva AMV; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Linhares JHR; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Dos Santos TP; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Mendes YS; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. de Lima SMB; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Fernandes CB; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. da Silva J; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. de Souza AF; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Tubarão LN; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Brito E Cunha D; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Pereira TBS; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Menezes CEL; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Miranda MD; Laboratório de Vírus Respiratório e do Sarampo, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Matos AR; Laboratório de Vírus Respiratório e do Sarampo, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. CaetanoBC; Laboratório de Vírus Respiratório e do Sarampo, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Martins JSCC; Laboratório de Vírus Respiratório e do Sarampo, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Calvo TL; Laboratório de Hanseníase, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Rodrigues NF; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.; Centro de Desenvolvimento Tecnológico em Saúde, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Sacramento CQ; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.; Centro de Desenvolvimento Tecnológico em Saúde, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Siqueira MM; Laboratório de Vírus Respiratório e do Sarampo, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Moraes MO; Laboratório de Hanseníase, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Missailidis S; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Neves PCC; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil. Ano Bom APD; Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Pokaż więcej
Źródło:
Cells [Cells] 2021 Aug 26; Vol. 10 (9). Date of Electronic Publication: 2021 Aug 26.
Clinical impact of respiratory virus in pulmonary exacerbations of children with Cystic Fibrosis.
Autorzy:
Meyer VMC; Respiratory Virus and Measles Laboratory, Oswaldo Cruz Institute - IOC/FIOCRUZ, Rio de Janeiro, Brazil. Siqueira MM; Respiratory Virus and Measles Laboratory, Oswaldo Cruz Institute - IOC/FIOCRUZ, Rio de Janeiro, Brazil. Costa PFBM; Pulmonology Department, National Institute of Women, Children and Adolescents Health Fernandes Figueira - IFF/FIOCRUZ, Rio de Janeiro, Brazil.; Pediatrics Department, Federal University of the State of Rio de Janeiro - UNIRIO, Rio de Janeiro, Brazil. CaetanoBC; Respiratory Virus and Measles Laboratory, Oswaldo Cruz Institute - IOC/FIOCRUZ, Rio de Janeiro, Brazil. Oliveira Lopes JC; Respiratory Virus and Measles Laboratory, Oswaldo Cruz Institute - IOC/FIOCRUZ, Rio de Janeiro, Brazil. Folescu TW; Pulmonology Department, National Institute of Women, Children and Adolescents Health Fernandes Figueira - IFF/FIOCRUZ, Rio de Janeiro, Brazil. Motta FDC; Respiratory Virus and Measles Laboratory, Oswaldo Cruz Institute - IOC/FIOCRUZ, Rio de Janeiro, Brazil.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Oct 28; Vol. 15 (10), pp. e0240452. Date of Electronic Publication: 2020 Oct 28 (Print Publication: 2020).
The Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruzi.
Autorzy:
Ersching J; Centro de Terapia Celular e Molecular and Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, São Paulo, Brazil. Vasconcelos JR; Centro de Terapia Celular e Molecular and Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, São Paulo, Brazil.; Departamento de Biociências, Universidade Federal de São Paulo, Santos, São Paulo, Brazil. Ferreira CP; Centro de Terapia Celular e Molecular and Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, São Paulo, Brazil. CaetanoBC; Departments of Medicine and Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America. Machado AV; Centro de Pesquisas René Rachou, FIOCRUZ, Belo Horizonte, Minas Gerais, Brazil. Bruna-Romero O; Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazil. Baron MA; Instituto do Coração (InCor), Faculdade de Medicina - Universidade de São Paulo, São Paulo, São Paulo, Brazil. Ferreira LR; Instituto do Coração (InCor), Faculdade de Medicina - Universidade de São Paulo, São Paulo, São Paulo, Brazil.; Universidade Santo Amaro, São Paulo, São Paulo, Brazil. Cunha-Neto E; Instituto do Coração (InCor), Faculdade de Medicina - Universidade de São Paulo, São Paulo, São Paulo, Brazil. Rock KL; Departments of Medicine and Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America. Gazzinelli RT; Departments of Medicine and Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.; Centro de Pesquisas René Rachou, FIOCRUZ, Belo Horizonte, Minas Gerais, Brazil.; Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. Rodrigues MM; Centro de Terapia Celular e Molecular and Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, São Paulo, Brazil.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2016 Apr 29; Vol. 12 (4), pp. e1005593. Date of Electronic Publication: 2016 Apr 29 (Print Publication: 2016).
Serum 25-Hydroxyvitamin D Levels are not Associated with Adverse Outcomes in Clostridium Difficile Infection.
Autorzy:
Micic D; Division of Gastroenterology, Hepatology and Nutrition, University of Chicago , IL, USA. Rao K; Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI, USA ; Division of Infectious Diseases, University of Michigan Health System , Ann Arbor, MI, USA. Trindade BC; Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI, USA ; Department of Microbiology and Immunology, University of Michigan Health System , Ann Arbor, MI, USA. Walk ST; Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI, USA ; Division of Infectious Diseases, University of Michigan Health System , Ann Arbor, MI, USA. Chenoweth E; University of Michigan Medical School , Ann Arbor, MI, USA. Jain R; Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI, USA ; Division of Infectious Diseases, University of Michigan Health System , Ann Arbor, MI, USA. Trivedi I; Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI, USA. Santhosh K; Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI, USA ; Division of Infectious Diseases, University of Michigan Health System , Ann Arbor, MI, USA. Young VB Aronoff DM
Pokaż więcej
Źródło:
Infectious disease reports [Infect Dis Rep] 2015 Sep 29; Vol. 7 (3), pp. 5979. Date of Electronic Publication: 2015 Sep 29 (Print Publication: 2015).
Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.
Autorzy:
Starling AL; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil .; b Fundação Centro De Hematologia E Hemoterapia De Minas Gerais - HEMOMINAS , Santa Efigênia, Minas Gerais , Brazil .; c Programa De Pós-Graduação Em Infectologia E Medicina Tropical - Faculdade De Medicina Da Universidade Federal De Minas Gerais , Belo Horizonte, Minas Gerais , Brazil . Coelho-Dos-Reis JG; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil . Peruhype-Magalhães V; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil . Pascoal-Xavier MA; c Programa De Pós-Graduação Em Infectologia E Medicina Tropical - Faculdade De Medicina Da Universidade Federal De Minas Gerais , Belo Horizonte, Minas Gerais , Brazil .; d Department of Anatomic Pathology , Medicine School, Federal University of Minas Gerais , Belo Horizonte, Minas Gerais , Brazil . Gonçalves DU; c Programa De Pós-Graduação Em Infectologia E Medicina Tropical - Faculdade De Medicina Da Universidade Federal De Minas Gerais , Belo Horizonte, Minas Gerais , Brazil . Béla SR; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil . Lambertucci JR; c Programa De Pós-Graduação Em Infectologia E Medicina Tropical - Faculdade De Medicina Da Universidade Federal De Minas Gerais , Belo Horizonte, Minas Gerais , Brazil . Labanca L; c Programa De Pós-Graduação Em Infectologia E Medicina Tropical - Faculdade De Medicina Da Universidade Federal De Minas Gerais , Belo Horizonte, Minas Gerais , Brazil . Souza Pereira SR; c Programa De Pós-Graduação Em Infectologia E Medicina Tropical - Faculdade De Medicina Da Universidade Federal De Minas Gerais , Belo Horizonte, Minas Gerais , Brazil . Teixeira-Carvalho A; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil . Ribas JG; e Hospital Sarah Kubitschek , Belo Horizonte, Minas Gerais , Brazil , and. Trindade BC; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil .; f Laboratório De Inflamação E Imunologia Das Parasitoses , Faculdade De Ciências Farmacêuticas De Ribeirão Preto, Universidade De São Paulo , Ribeirão Preto, São Paulo , Brazil. Faccioli LH; f Laboratório De Inflamação E Imunologia Das Parasitoses , Faculdade De Ciências Farmacêuticas De Ribeirão Preto, Universidade De São Paulo , Ribeirão Preto, São Paulo , Brazil. Carneiro-Proietti AB; b Fundação Centro De Hematologia E Hemoterapia De Minas Gerais - HEMOMINAS , Santa Efigênia, Minas Gerais , Brazil . Martins-Filho OA; a Centro De Pesquisas René Rachou - FIOCRUZ-Minas , Belo Horizonte, Minas Gerais , Brazil .
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies